Medical Marketing and Media | Celgene buys into anticancer antibodies Chemistry World US firms Celgene and OncoMed have tied up a deal to develop and commercialise biological therapies for cancer. The deal gives Celgene access to six antibody products in OncoMed's pipeline, designed to target cancer stem cells rather than regular tumour ... Who Benefits From the OncoMed and Celgene Partnership? Celgene Plunks Down $177M Upfront for OncoMed's Stem Cell Drugs Celgene, OncoMed in $177M Cancer Stem Cell... |
